Natriuretic Peptide, Brain
"Natriuretic Peptide, Brain" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A PEPTIDE that is secreted by the BRAIN and the HEART ATRIA, stored mainly in cardiac ventricular MYOCARDIUM. It can cause NATRIURESIS; DIURESIS; VASODILATION; and inhibits secretion of RENIN and ALDOSTERONE. It improves heart function. It contains 32 AMINO ACIDS.
| Descriptor ID |
D020097
|
| MeSH Number(s) |
D06.472.699.584.625 D12.644.548.585.625 D12.776.631.590
|
| Concept/Terms |
Natriuretic Peptide, Brain- Natriuretic Peptide, Brain
- Peptide, Brain Natriuretic
- BNP-32
- BNP 32
- Brain Natriuretic Peptide-32
- Brain Natriuretic Peptide 32
- Natriuretic Peptide-32, Brain
- Peptide-32, Brain Natriuretic
- Natriuretic Factor-32
- Natriuretic Factor 32
- BNP Gene Product
- Type-B Natriuretic Peptide
- Natriuretic Peptide, Type-B
- Type B Natriuretic Peptide
- Natriuretic Peptide Type-B
- Natriuretic Peptide Type B
- Nesiritide
- Brain Natriuretic Peptide
- B-Type Natriuretic Peptide
- Natriuretic Peptide, B-Type
|
Below are MeSH descriptors whose meaning is more general than "Natriuretic Peptide, Brain".
Below are MeSH descriptors whose meaning is more specific than "Natriuretic Peptide, Brain".
This graph shows the total number of publications written about "Natriuretic Peptide, Brain" by people in this website by year, and whether "Natriuretic Peptide, Brain" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2009 | 1 | 0 | 1 |
| 2012 | 2 | 0 | 2 |
| 2013 | 0 | 1 | 1 |
| 2014 | 1 | 0 | 1 |
| 2015 | 0 | 1 | 1 |
| 2016 | 3 | 0 | 3 |
| 2017 | 4 | 0 | 4 |
| 2018 | 1 | 1 | 2 |
| 2019 | 2 | 0 | 2 |
| 2020 | 1 | 4 | 5 |
| 2021 | 1 | 1 | 2 |
| 2022 | 0 | 2 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Natriuretic Peptide, Brain" by people in Profiles.
-
Framingham and American College of Cardiology/American Heart Association Pooled Cohort Equations, High-Sensitivity Troponin T, and N-Terminal Pro-Brain-Type Natriuretic Peptide for Predicting Atherosclerotic Cardiovascular Events Across the Spectrum of Kidney Dysfunction. J Am Heart Assoc. 2022 Jun 07; 11(11):e024913.
-
A randomized controlled trial of renin-angiotensin-aldosterone system inhibitor management in patients admitted in hospital with COVID-19. Am Heart J. 2022 May; 247:76-89.
-
Prognostic Value of Natriuretic Peptides and Cardiac Troponins in COVID-19. Circulation. 2021 07 13; 144(2):177-179.
-
Bias in natriuretic peptide-guided heart failure trials: time to improve guideline adherence using alternative approaches. Heart Fail Rev. 2021 01; 26(1):11-21.
-
The Degree of the Predischarge Pulmonary Congestion in Patients Hospitalized for Worsening Heart Failure Predicts Readmission and Mortality. Cardiology. 2021; 146(1):49-59.
-
Association of Cardiac Biomarkers With the Kansas City Cardiomyopathy Questionnaire in Patients With Chronic Kidney Disease Without Heart Failure. J Am Heart Assoc. 2020 07 07; 9(13):e014385.
-
Sacubitril/Valsartan in Advanced Heart Failure With Reduced Ejection Fraction: Rationale and Design of the LIFE Trial. JACC Heart Fail. 2020 10; 8(10):789-799.
-
Initiation of Angiotensin-Neprilysin Inhibition After Acute Decompensated Heart Failure: Secondary Analysis of the Open-label Extension of the PIONEER-HF Trial. JAMA Cardiol. 2020 02 01; 5(2):202-207.
-
A Novel In-hospital Congestion Score to Risk Stratify Patients Admitted for Worsening Heart Failure (from ASCEND-HF). J Cardiovasc Transl Res. 2020 08; 13(4):540-548.
-
Are existing and emerging biomarkers associated with cardiorespiratory fitness in patients with chronic heart failure? Am Heart J. 2020 02; 220:97-107.